Canyondan

[Canyondan @Canyondan]

@JoWesCo69 @drawandstrike @grok Would these conspirators be subject to military tribunals @grok

[Bad Kitty Unleashed 🦁 💪🏻 @pepesgrandma]

Bad Kitteh burns it all down. Phone recording of a Chinese factory customizing forged ballots for 2020.

“The ongoing controversy over the U.S. presidential election has severely damaged global confidence in the democratic system. Now sources have confirmed that since July this year, China has forged about 1.5 million blank U.S. ballots and exported them to Canada, Mexico and other places before disappearing.”

Linkie to follow. The first video account has been terminated by YouTube as expected.

[Canyondan @Canyondan]

@WallStreetApes Soon to be military tribunals hopefully. 🤞

[Forest Park Pharmacy @ForestParkPharm]

This is the story of the most expensive generic drug in the world, and how it is quietly bankrupting Medicare while it enriches the manufacturers and the middlemen at the same time.

It is lenalidomide, the generic of Revlimid, a blood cancer drug. And it costs nearly $14,000 a prescription. For a generic. In 2023 it was the single biggest generic drug in all of Medicare, at $1.68 billion. The number two generic on that list costs about $15 a claim. This one costs $13,806.

So how does a generic pull that off? It went off patent in 2019, but Bristol Myers Squibb had just bought it, and on the way in they negotiated three more years of market exclusivity. I have no idea how that is legal, but it happens constantly.

It became broadly generic in 2022. But here is the trick. It is still under restricted distribution, which means the manufacturer only lets about 21 pharmacies in the entire country sell it. A pharmacy like mine cannot even touch it. So we cannot compete and drive the price down. They did not win the market. They deleted it.

And when you look at who owns those 21 pharmacies, surprise, it is mostly the PBMs and insurers themselves. CVS, Cigna, Centene, Optum, Prime.

With no real market, why would any manufacturer compete on price? They do not. Several companies make this drug and they all somehow land on the same high number. And it is making them a fortune. For Dr. Reddy's, this one drug is over 80 percent of its revenue growth. These are companies with hundreds of products, leaning on a single generic.

The manufacturers are not the only ones cashing in. Your insurer is too, because lenalidomide is classified as a specialty drug. Specialty drugs are less than 2 percent of prescriptions but half of all drug spending. What makes a drug specialty? Nobody can tell you, other than it is expensive. And once that label is on, the insurer cranks the knobs. They raise the price and they limit where you can fill it.

Look at a different drug, abiraterone. It costs about $188. CVS charges $6,372 for it, then steers half of all patients to the pharmacy CVS itself owns, so they capture every last cent.

Add it all up and lenalidomide is on track to cost Americans around $3.5 billion, roughly 8 percent of all Medicare drug spending. A generic taken by about 20,000 people is propping up the entire ecosystem. That is insane.

Firing the middleman will not fix every problem with a drug like this. The restricted distribution is a separate fight. But it takes care of a whole lot of the damage, so that is exactly what we did. No PBM in the middle means fair, transparent prices you can actually see.

Sources: CMS Medicare Part D, 46brooklyn Research, and the Lenalidomide REMS program.

[James O'Keefe @JamesOKeefeIII]

Today, I testified before the U.S. Senate at the “Exposing Fraud in America” hearing.

I shared what OMG exposed on hidden camera: petition circulators paying homeless individuals cash and offering drugs in exchange for voter registrations and ballot petition signatures, forged signatures using the names and addresses of real registered voters, and how our reporting helped lead to a federal criminal indictment.

My opening statement to the Committee was simple:

“There is money in fraud. There’s no money in exposing the fraud.”

I am an American journalist that is fed up. My job is to expose the truth. Fraud must be stopped.

If you have evidence of fraud involving Medicaid, USDA, SNAP, unemployment benefits, SBA programs, or other government waste or abuse, we want to hear from you. There are fast acting government agencies that will reform now if we get the evidence.

Send us your tips by DM, email us at [email protected], or call our tip line at 914-491-9395.

Your tip could be the start of our next investigation.

[Canyondan @Canyondan]

@deryaa1214 A really hosed up clock

[Blue Lives Matter @bluelivesmtr]

On behalf of the largest police news outlet in the world, we're officially calling for the resignation or termination of this officer IMMEDIATELY.

A female Fort Worth police officer was caught on camera threatening to ticket a retired federal law enforcement officer and Christian street preacher for “offensive speech.”

The officer told the man that if someone is offended by his preaching, then “we have a problem” and said she would issue him a ticket. When he asked if she was really going to ticket him for offensive speech, she replied, “Yes, I am.”

This is a blatant violation of the First Amendment. Police officers do not have the authority to ticket people for speech that offends others. That is the exact opposite of how freedom of speech works in America.

The fact that this officer targeted a retired federal law enforcement officer who was simply preaching makes this even more unacceptable.

Departments that employ officers who openly disregard the Constitution need to clean house. This kind of behavior erodes public trust and makes every good officer’s job harder.

Pass this along so more people see what is happening on our streets.

#FortWorthPD #FirstAmendment

[Canyondan @Canyondan]

@libsoftiktok @instapundit @WFCPreacher @KenPaxtonTX can you help interpret this situation. Seems that someone’s first amendment rights are being violated. Thanks

[Canyondan @Canyondan]

@JulieNessen @JohnDParody Sauerkraut and Kimchi

[Canyondan @Canyondan]

@ronsterd89 77

[Canyondan @Canyondan]

@usludurkizim You changed deodorants and was allergic to it

[Canyondan @Canyondan]

@Beno10_MFC D the shaft on the beater is longer or more exposed

[Canyondan @Canyondan]

@kiara_whispers 176

[Canyondan @Canyondan]

@grok @TyTyrone4 @ThePatriotOasis That’s good but I honestly cannot believe any of your sources

[Canyondan @Canyondan]

@TyTyrone4 @ThePatriotOasis @grok Where did @grok get his information. What sources @grok

[Holy Bible @Holy__Bible1]

𝐻𝑒𝑎𝑣𝑒𝑛𝑙𝑦 𝐹𝑎𝑡ℎ𝑒𝑟, 𝐼 𝑐𝑜𝑚𝑒 𝑡𝑜 𝑌𝑜𝑢 𝑤𝑖𝑡ℎ 𝑚𝑦 𝑎𝑛𝑥𝑖𝑜𝑢𝑠 ℎ𝑒𝑎𝑟𝑡. 𝑌𝑜𝑢 𝑘𝑛𝑜𝑤 𝑒𝑣𝑒𝑟𝑦 𝑤𝑜𝑟𝑟𝑦, 𝑒𝑣𝑒𝑟𝑦 𝑓𝑒𝑎𝑟, 𝑎𝑛𝑑 𝑒𝑣𝑒𝑟𝑦 𝑏𝑢𝑟𝑑𝑒𝑛 𝐼 𝑐𝑎𝑟𝑟𝑦. 𝑃𝑙𝑒𝑎𝑠𝑒 𝑐𝑎𝑙𝑚 𝑚𝑦 𝑚𝑖𝑛𝑑 𝑎𝑛𝑑 𝑔𝑖𝑣𝑒 𝑚𝑒 𝑌𝑜𝑢𝑟 𝑝𝑒𝑎𝑐𝑒 𝑡ℎ𝑎𝑡 𝑖𝑠 𝑔𝑟𝑒𝑎𝑡𝑒𝑟 𝑡ℎ𝑎𝑛 𝑎𝑙𝑙 𝑢𝑛𝑑𝑒𝑟𝑠𝑡𝑎𝑛𝑑𝑖𝑛𝑔. 𝐻𝑒𝑙𝑝 𝑚𝑒 𝑟𝑒𝑙𝑒𝑎𝑠𝑒 𝑡ℎ𝑒 𝑡ℎ𝑖𝑛𝑔𝑠 𝐼 𝑐𝑎𝑛𝑛𝑜𝑡 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑎𝑛𝑑 𝑡𝑟𝑢𝑠𝑡 𝑌𝑜𝑢 𝑤𝑖𝑡ℎ 𝑤ℎ𝑎𝑡 𝑙𝑖𝑒𝑠 𝑎ℎ𝑒𝑎𝑑. 𝑅𝑒𝑝𝑙𝑎𝑐𝑒 𝑚𝑦 𝑓𝑒𝑎𝑟 𝑤𝑖𝑡ℎ 𝑓𝑎𝑖𝑡ℎ, 𝑚𝑦 𝑡𝑒𝑛𝑠𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝑟𝑒𝑠𝑡, 𝑎𝑛𝑑 𝑚𝑦 𝑐𝑜𝑛𝑓𝑢𝑠𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝑐𝑙𝑎𝑟𝑖𝑡𝑦. 𝐺𝑖𝑣𝑒 𝑚𝑒 𝑠𝑡𝑟𝑒𝑛𝑔𝑡ℎ 𝑓𝑜𝑟 𝑡𝑜𝑑𝑎𝑦 𝑎𝑛𝑑 ℎ𝑜𝑝𝑒 𝑓𝑜𝑟 𝑡𝑜𝑚𝑜𝑟𝑟𝑜𝑤. 𝑅𝑒𝑚𝑖𝑛𝑑 𝑚𝑒 𝑡ℎ𝑎𝑡 𝐼 𝑎𝑚 𝑛𝑒𝑣𝑒𝑟 𝑎𝑙𝑜𝑛𝑒, 𝑡ℎ𝑎𝑡 𝑌𝑜𝑢 𝑎𝑟𝑒 𝑤𝑖𝑡ℎ 𝑚𝑒 𝑖𝑛 𝑒𝑣𝑒𝑟𝑦 𝑚𝑜𝑚𝑒𝑛𝑡, 𝑎𝑛𝑑 𝑡ℎ𝑎𝑡 𝑌𝑜𝑢𝑟 𝑙𝑜𝑣𝑒 𝑖𝑠 𝑠𝑡𝑟𝑜𝑛𝑔𝑒𝑟 𝑡ℎ𝑎𝑛 𝑚𝑦 𝑎𝑛𝑥𝑖𝑒𝑡𝑦. 𝐿𝑒𝑡 𝑌𝑜𝑢𝑟 𝑝𝑟𝑒𝑠𝑒𝑛𝑐𝑒 𝑏𝑟𝑖𝑛𝑔 𝑐𝑜𝑚𝑓𝑜𝑟𝑡 𝑎𝑛𝑑 ℎ𝑒𝑎𝑙𝑖𝑛𝑔 𝑡𝑜 𝑚𝑦 ℎ𝑒𝑎𝑟𝑡. 𝐼𝑛 𝐽𝑒𝑠𝑢𝑠’ 𝑛𝑎𝑚𝑒, 𝐴𝑚𝑒𝑛.

[Canyondan @Canyondan]

@JohnDParody Go JD.

[Forest Park Pharmacy @ForestParkPharm]

My wife and I own a pharmacy. Last month we spent days trying to pry one prescription loose from a company that did everything it could to hold onto it.

The drug was everolimus. A generic. It treats cancer and protects transplant patients from rejecting their new organ. Not exotic. Not rare. A pill.

The patient wanted it filled with us because we're cash-pay and cost-plus. No insurance. No PBM. No secret markups, no games. Our price was $318. That's not cheap by our standards — most of what we fill runs under $20 — but it was honest.

Here's what that same prescription looked like on the other side of the counter.

In 2023, Medicare was paying about $6,645 for it. That's roughly 21 times our price for the identical medication. Medicare spent around $240 million on everolimus alone that year. If they'd paid our price, they'd have saved roughly $230 million. On one generic drug.

So how does an insurance company profit off a drug that expensive? Don't they pay for it?

No. You pay for it. In your premiums. Their job isn't to spend less — it's to keep your healthcare dollars circulating inside their own companies. And the tool they use is called spread pricing.

Spread pricing works like this: the middleman bills the health plan one price, pays the pharmacy a lower one, and keeps the difference. You never see it. On TRICARE, they pay an independent pharmacy like mine about $311 to fill everolimus. That barely covers our cost of the drug. Meanwhile the plan gets billed thousands. That gap — north of $6,000 on a single fill — is pure margin the middleman pockets.

Now here's the part they'd rather you not think about.

The pharmacy we were fighting was Accredo. Accredo is owned by Express Scripts. Express Scripts is the pharmacy benefit manager owned by Cigna. Same company, three masks. That nesting-doll structure isn't an accident — it's the whole design. When the pharmacy, the PBM, and the insurer are all one entity, they can shuffle money between their own pockets and call it whatever they want. The confusion is the product.

And this isn't a story about one weird drug. It's the business model.

The FTC has been digging into exactly this. In its January 2025 report on the three biggest PBMs — CVS Caremark, Express Scripts, and OptumRx — staff found those companies marked up specialty generic drugs by hundreds and thousands of percent when dispensing through their own affiliated pharmacies. Just those markups generated more than $7.3 billion above what the drugs actually cost to acquire, from 2017 to 2022. One in five of the specialty generics they studied was marked up over 1,000%. Some cancer generics: over 3,000%. On top of that, the FTC pegged spread pricing on those same drugs at another $1.4 billion.

One example straight from the FTC's files: dimethyl fumarate, a multiple sclerosis drug. Costs about $177 to acquire. The PBMs paid their own pharmacies close to $4,000 for a 30-day supply. Same trick. Different drug.

And they steer the profitable ones to themselves on purpose. Pharmacies affiliated with the big three took in 68% of specialty dispensing revenue in 2023 — up from 54% in 2016. The prescriptions marked up more than $1,000 disproportionately end up at their own pharmacies, not independents like mine.

So when we called to transfer this patient's everolimus to be filled without insurance, it landed like we were asking them to set $6,000 on fire. Of course they stonewalled us.

That's why we fired them.

No insurance means no invisible $6,000 charge buried in a premium you can't itemize. It means the price you see is the price. Ours was $318. Theirs was thousands. Same pill.

[Canyondan @Canyondan]

@JohnDParody 😂